Dimensional Fund Advisors
MRVI icon

Dimensional Fund Advisors’s Maravai LifeSciences MRVI Stock Holding History

Dimensional Fund Advisors’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.5M Sell
1,361,558
-57,039
-4% -$246K ﹤0.01% 2375
2026
Q1 		$4.02M Buy
1,418,597
+558,050
+65% +$1.89M ﹤0.01% 2564
2025
Q4 		$2.8M Sell
860,547
-76,008
-8% -$256K ﹤0.01% 2666
2025
Q3 		$2.69M Sell
936,555
-6,084
-0.6% -$15.5K ﹤0.01% 2696
2025
Q2 		$2.27M Sell
942,639
-313,141
-25% -$658K ﹤0.01% 2730
2025
Q1 		$2.78M Sell
1,255,780
-55,920
-4% -$221K ﹤0.01% 2641
2024
Q4 		$7.15M Buy
1,311,700
+221,908
+20% +$1.43M ﹤0.01% 2431
2024
Q3 		$9.06M Buy
1,089,792
+431,395
+66% +$3.73M ﹤0.01% 2338
2024
Q2 		$4.71M Sell
658,397
-145,061
-18% -$1.25M ﹤0.01% 2508
2024
Q1 		$6.97M Sell
803,458
-117,203
-13% -$793K ﹤0.01% 2457
2023
Q4 		$6.03M Sell
920,661
-217,881
-19% -$1.41M ﹤0.01% 2511
2023
Q3 		$11.4M Buy
1,138,542
+211,370
+23% +$2.32M ﹤0.01% 2185
2023
Q2 		$11.5M Buy
927,172
+550,964
+146% +$7.44M ﹤0.01% 2189
2023
Q1 		$5.27M Buy
+376,208
New +$5.4M ﹤0.01% 2473
2022
Q3 		$8.63M Sell
338,151
-8,855
-3% -$222K ﹤0.01% 2215
2022
Q2 		$9.86M Buy
347,006
+229,847
+196% +$7.28M ﹤0.01% 2204
2022
Q1 		$4.13M Buy
117,159
+98,698
+535% +$3.31M ﹤0.01% 2594
2021
Q4 		$774K Buy
18,461
+771
+4% +$31.2K ﹤0.01% 3081
2021
Q3 		$868K Buy
+17,690
New +$863K ﹤0.01% 3072

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Dimensional Fund Advisors's MRVI Position: Q2 2026 in Review

Dimensional Fund Advisors reduced its Maravai LifeSciences (MRVI) stake by 4% in Q2 2026, selling an estimated $246K and leaving 1,361,558 shares worth $8.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2375.

Dimensional Fund Advisors first reported a position in MRVI in Q3 2021 and has held it in 19 quarters since. The position peaked at $11.5M in Q2 2023. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Dimensional Fund Advisors held 1,361,558 shares of Maravai LifeSciences worth $8.5M as of Q2 2026.
  • Dimensional Fund Advisors sold 57,039 Maravai LifeSciences shares in Q2 2026, an estimated $246K.
  • Maravai LifeSciences made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2375 holding.
  • Dimensional Fund Advisors first reported a position in Maravai LifeSciences in Q3 2021 and has held it in 19 quarters since.
  • Dimensional Fund Advisors's Maravai LifeSciences position peaked at $11.5M in Q2 2023.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.